AI Summary
Researchers have published successful results from a Phase II clinical trial for treating BRAF mutated low-grade pediatric gliomas.
A collaboration of researchers has published successful results from a Phase II clinical trial for the treatment of BRAF mutated low-grade paediatric gliomas.